The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 254.00
Bid: 255.00
Ask: 256.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.392%)
Open: 254.00
High: 259.50
Low: 254.00
Prev. Close: 254.00
CMCX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to ESMA Proposals

18 Dec 2017 07:00

RNS Number : 5761Z
CMC Markets Plc
18 December 2017
 

18 December 2017

 

 

CMC Markets Plc

 

Response to ESMA Proposals

 

 

CMC Markets Plc ("CMC") notes the announcement by the European Securities and Markets Authority (ESMA) issued on Friday 15 December, further to announcements made by the Financial Conduct Authority and other European regulators in December 2016 and June 2017.

 

This announcement includes proposals to improve investor protection for retail clients, and ESMA will conduct a brief consultation in January 2018 on the matter.

 

The proposals include the following:-

 

1. Prohibit the marketing, distribution or sale to retail clients of binary options; and

2. Restrict the marketing, distribution or sale to retail clients of CFDs, including rolling spot forex.

 

Restrictions on CFDs under review are:

- leverage limits on the opening of a position between 30:1 and 5:1, whose limit will vary according to the volatility of the underlying asset;

- a margin close-out rule;

- negative balance protection to provide a guaranteed limit on client losses;

- a restriction on benefits incentivising trading; and

- a standardised risk warning.

 

Through its proprietary technology CMC can quickly respond to regulatory change as illustrated with the introduction of negative balance protection in Germany and a limited risk product in the UK this year. Fair client outcomes have always been a focus, with margin close-out and standardised risk warnings already in place throughout the Group.

 

Binary products generated £2.1m of revenues from the UK and Europe in H1 18 and therefore any prohibition on the marketing of binary options to retail clients will be immaterial in a group context. Proposed margin changes are likely to have an impact on how clients trade, although at this stage it is not possible to quantify the impact.

 

The Group has focused on higher value clients and has one of the highest revenue per clients in the industry. This coupled with geographic diversity, growing institutional business and a partnership with ANZ Bank to provide stockbroking services in Australia from September 2018, will help to mitigate any impact from ESMA's proposals.

 

Whilst these proposed changes may have an impact on the Group, CMC welcomes a consistent approach to regulation, a 'level playing field' and the raising of standards in the industry. The Group's focus on attracting high value and experienced clients and its strong balance sheet, means that CMC is well positioned to take advantage of market opportunities that will arise from these proposals.

 

 

 

Enquiries

 

Camarco +44 (0) 20 3757 4984

Geoffrey Pelham-Lane

Ed Gascoigne-Pees

Jennifer Renwick

 

 

 

 

Notes to Editors

CMC Markets plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX, was established in 1989 and is now one of the world's leading online financial trading businesses. The company serves retail and institutional clients through regulated offices and branches in 14 countries, with a significant presence in the UK, Australia, Germany and Singapore. CMC Markets offers an award-winning, online and mobile trading platform, enabling clients to trade over 10,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RSPUBOKRBNAUAAA
Date   Source Headline
21st Jul 20212:15 pmRNSDirector/PDMR Shareholding
13th Jul 20219:45 amRNSIssue of Equity
12th Jul 20212:23 pmRNSDirector/PDMR Shareholding
9th Jul 202112:34 pmRNSDirector/PDMR Shareholding
25th Jun 20214:46 pmRNSNotice of AGM
10th Jun 20219:58 amRNSDirector/PDMR Shareholding
10th Jun 20217:00 amRNSFinal Results
10th May 202110:15 amRNSDirector/PDMR Shareholding
9th Apr 20213:43 pmRNSDirector/PDMR Shareholding
9th Apr 20213:39 pmRNSDirector/PDMR Shareholding
25th Mar 20213:55 pmRNSBoard Committee Changes
25th Mar 20217:00 amRNSFY 2021 Pre-Close Trading Update
10th Mar 20213:00 pmRNSHolding(s) in Company
10th Mar 202111:48 amRNSDirector/PDMR Shareholding
24th Feb 20219:43 amRNSHolding(s) in Company
10th Feb 20213:01 pmRNSDirector/PDMR Shareholding
10th Feb 20212:30 pmRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSCMC selects AWS to improve product delivery
20th Jan 20217:00 amRNSQ3 2021 Trading Update
11th Jan 202111:15 amRNSDirector/PDMR Shareholding
24th Dec 20209:55 amRNSDirector/PDMR Shareholding
24th Dec 20209:33 amRNSDirector/PDMR Shareholding
9th Dec 202011:44 amRNSDirector/PDMR Shareholding
1st Dec 202012:25 pmRNSDirector/PDMR Shareholding
23rd Nov 202011:58 amRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSInterim results
10th Nov 202010:06 amRNSDirector/PDMR Shareholding
26th Oct 20207:00 amRNSAppointment of Joint Corporate Broker
23rd Oct 20208:44 amRNSCMC welcomes ASIC consultation paper outcome
8th Oct 20207:00 amRNSTrading Update
6th Oct 20202:51 pmRNSDirector/PDMR Shareholding
22nd Sep 20204:45 pmRNSDirector/PDMR Shareholding
17th Sep 20204:19 pmRNSDirector/PDMR Shareholding
14th Sep 20209:15 amRNSIssue of Equity
9th Sep 20204:02 pmRNSDirector/PDMR Shareholding
9th Sep 20203:58 pmRNSHolding(s) in Company
3rd Sep 20207:00 amRNSTrading Update
2nd Sep 202010:40 amRNSCompliance with Listing Rule 9.2.6E
10th Aug 202011:34 amRNSDirector/PDMR Shareholding
30th Jul 20204:08 pmRNSRESULTS OF 2020 ANNUAL GENERAL MEETING
30th Jul 20201:58 pmRNSDirector/PDMR Shareholding
20th Jul 20202:14 pmRNSHolding(s) in Company
13th Jul 20207:00 amRNSAppointment of Chief Technology Officer
8th Jul 20203:41 pmRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSQ1 2021 Trading Update
11th Jun 20207:00 amRNSFinal results
8th Jun 20202:59 pmRNSDirector/PDMR Shareholding
7th May 20204:44 pmRNSDirector/PDMR Shareholding
8th Apr 20208:35 amRNSDirector/PDMR Shareholding
3rd Apr 20207:00 amRNSFY 2020 Pre-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.